NLRP3 and breast cancer: Given the aberrant activation of ROS–NRF2–HO-1–NF-кB axis in DPP-4i-treated BC cells, we explored potential roles of ROS–NRF2–HO-1–NF-кB axis in DPP-4i-driven NLRP3 inflammasome activation in BC cells.